Taysha Gene Therapies Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun '24 Jun 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Cash & Equivalents	172.74	143.94	87.88	149.1	251.25	-
Cash & Short-Term Investments	172.74	143.94	87.88	149.1	251.25	-
Cash Growth	283.17%	63.79%	-41.06%	-40.66%	-	-
Prepaid Expenses	0.97	1.09	2.51	3.87	3.83	-
Restricted Cash	0.45	0.45	-	-	-	-
Other Current Assets	4.31	4.39	6.03	6.63	2.79	0.02
Total Current Assets	178.47	149.87	96.42	159.6	257.88	0.02
Property, Plant & Equipment	19.48	20.41	25.91	50.61	0.29	-
Other Long-Term Assets	2.44	2.46	3.95	3.74	0.72	-
Total Assets	200.39	172.73	126.28	213.96	258.88	0.02
Accounts Payable	8.72	6.37	10.95	21.76	1.99	-
Accrued Expenses	8.75	9.46	14.04	25.85	4.87	0.13
Current Portion of Leases	1.75	1.65	1.52	-	-	-
Current Unearned Revenue	13.58	18.11	33.56	-	-	-
Other Current Liabilities	1.37	1.18	2.73	4.14	0.26	0.02
Total Current Liabilities	34.18	36.76	62.79	51.75	7.13	0.15
Long-Term Debt	37.84	40.51	37.97	37.19	-	-
Long-Term Leases	18.71	19.73	20.44	25.9	-	-
Other Long-Term Liabilities	0.8	0.8	4.13	3.74	0.45	-
Total Liabilities	91.53	97.79	125.33	118.57	7.58	0.15
Common Stock	0	0	0	-	-	-
Additional Paid-In Capital	664.46	587.94	402.39	331.03	312.43	0.98
Retained Earnings	-558	-513.01	-401.44	-235.65	-61.13	-1.12
Shareholders' Equity	108.87	74.94	0.95	95.38	251.3	-0.14
Total Liabilities & Equity	200.39	172.73	126.28	213.96	258.88	0.02
Total Debt	58.3	61.89	59.93	63.09	-	-
Net Cash (Debt)	114.44	82.06	27.95	86.01	251.25	-
Net Cash Growth	-	193.56%	-67.50%	-65.77%	-	-
Net Cash Per Share	0.57	0.71	0.64	2.28	14.22	-
Filing Date Shares Outstanding	204.94	187.02	63.47	38.47	37.76	10.9
Total Common Shares Outstanding	201.38	186.96	63.21	38.47	37.76	10.9
Working Capital	144.29	113.11	33.63	107.86	250.75	-0.14
Book Value Per Share	0.54	0.40	0.02	2.48	6.65	-0.01
Tangible Book Value	108.87	74.94	0.95	95.38	251.3	-0.14
Tangible Book Value Per Share	0.54	0.40	0.02	2.48	6.65	-0.01
Machinery	5.14	4.87	4.88	3.04	0.1	-
Construction In Progress	6.88	6.82	9.63	46	0.2	-
Leasehold Improvements	2.12	2.12	2.09	2.07	-	-

Source: S&P Capital IQ. Standard template. Financial Sources.